Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Lamivudine clinical results in HBV

May 29, 1997

Loxiglumide efficacy in GERD reported

May 29, 1997

Fujisawa's new agent for hepatic ischemia-reperfusion injury

May 29, 1997

Retrospective evaluation of immunosuppressive therapy for pediatric IBD

May 28, 1997

Oral methotrexate for severe IBD in children

May 28, 1997

Safety and efficacy of oral budesonide (Budenofalk) in Crohn's disease and collagenous colitis

May 28, 1997

Favorable clinical results with rifaximin in steroid-resistant ulcerative colitis

May 28, 1997

Promising initial clinical results for mycophenolate in IBD

May 28, 1997

Liposomal 5-ASA for IBD: pharmacokinetics in rat jejunum

May 28, 1997

Sagami prepares new anti-H. pylori agents

May 28, 1997

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...